AMRN:NASDAQ
Amarin Corporation PLC
$13.93
arrow_upward
+0.94%(+0.13) 1D
$13.93
0.00% (0.00)
bedtimeAfter hours
Closed: Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$13.89
High
$14.25
Low
$13.81
Mkt. cap
288.48M
Avg. vol.
77.62K
Volume
161.28K
52-wk high
$20.90
52-wk low
$11.65
EPS
-$14.58
Beta
0.82
Shares outstanding
20.97M
No. of employees
80
Open
$13.89
High
$14.25
Low
$13.81
Mkt. cap
288.48M
Avg. vol.
77.62K
Volume
161.28K
52-wk high
$20.90
52-wk low
$11.65
EPS
-$14.58
Beta
0.82
Shares outstanding
20.97M
No. of employees
80
News stories
From sources across the web
Yahoo Finance
·
1 hour ago
The Stock Market Is on the Verge of Doing Something Not Witnessed in 155 Years -- and the Implications for Wall Street Are Frightening
Minichart
·
36 minutes ago
Jupiter Neurosciences, Inc. Announces Amendment No. 3 to Executive Employment Agreement for Alison Silva – SEC 8-K Filing, Nasdaq Listed Emerging Growth Company 14151618
Simply Wall Street
·
59 minutes ago
Three Cryptocurrency And Blockchain Stocks Where AI Meets High P/E
Seeking Alpha
·
1 hour ago
Earnings Scoreboard100% of reporting S&P 500 firms beat earning expect
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com
AI content may include mistakes. Learn more